Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene.

The New England journal of medicine - 12 Oct 1995

Whelan A J, Bartsch D, Goodfellow P J

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Squamous Cell
Share to DNA
Share to Genes, Tumor Suppressor
Share to Melanoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplastic Syndromes, Hereditary

Share to Pancreatic Neoplasms

Share to Skin Neoplasms

Share to Syndrome

Source

Identifiers

PMID: 7666917
DOI: 10.1056/NEJM199510123331505

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene.PMID 7666917Read ↗

CDKN2A Gene Mutations: Implications for Hereditary Cancer SyndromesSemantic proximity Read ↗

Familial melanoma, pancreatic cancer and germline CDKN2A mutationsSemantic proximity Read ↗

The Role of Inherited Pathogenic CDKN2A Variants in Susceptibility to Pancreatic Cancer.Semantic proximity Read ↗

Patients with both pancreatic adenocarcinoma and melanoma may harbor germline CDKN2A mutations.Semantic proximity Read ↗

Increased prevalence of lung, breast, and pancreatic cancers in addition to melanoma risk in families bearing the cyclin-dependent kinase inhibitor 2A mutation: implications for genetic counseling.Semantic proximity Read ↗

Update on familial pancreatic cancer.Semantic proximity Read ↗

Pancreatic carcinoma surveillance in patients with familial melanoma.Semantic proximity Read ↗

German national case collection of familial pancreatic cancer - clinical-genetic analysis of the first 21 families.Semantic proximity Read ↗

Indication for CDKN2A-mutation analysis in familial pancreatic cancer families without melanomas.Semantic proximity Read ↗

Clinical and genetic analysis of 18 pancreatic carcinoma/melanoma-prone families.Semantic proximity Read ↗

Double germline mutations in APC and BRCA2 in an individual with a pancreatic tumor.Semantic proximity Read ↗

High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.